The additional glucagon receptor activation increases energy expenditure and fat burning, producing approximately 6 percentage points more weight loss in clinical trials (28.7% vs 22.5%)
Today, I review, link to, and excerpt from Whats New [Table 1] in the 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]
Key takeaways Microdosing means deliberately staying below the label ladders (Wegovy's standard ladder runs 0.25 to 2.4 mg, with a new 7.2 mg option approved in 2026
Phn u ly kem hi to nn d gy ra lng ph khi v tnh qu tay Trong thnh phn du khong, hng liu v cht bo qun
This is so regardless of the cause of the liver disease and provided the patient does not drink alcohol regularly
Is Southend Pharmacy the right compounding partner for a telehealth practice